Recent advances in stroke biomarkers – implications for prognosis and treatment
To translate these promising findings into clinical care and to identify novel molecular targets, standardized sample collection, rigorous external validation, and multiomics/panel integration will be required. In this sense, blood-based-biomarkers have the potential to sustainably improve diagnostics, prognosis and treatment in stroke care.
Authors
- Gerrit M. Große (ORCID: https://orcid.org/0000-0002-5335-9880)
- Mira Katan (ORCID: https://orcid.org/0000-0002-9265-8066)
- Johannes Frenger
- Jessica Seetge (ORCID: https://orcid.org/0000-0003-2912-0092)
Institutions
- University of Basel (CH)
- University Hospital of Basel (CH)
- Hospital Base (CL)
Publication Details
- Journal
- Current Opinion in Neurology
- Published
- 2025-11-28
- DOI
- https://doi.org/10.1097/wco.0000000000001450
- Primary Topic
- Acute Ischemic Stroke Management
- Type
- article
- Field-Weighted Citation Impact
- 0.00